GPT and cholestasis: Of the 4 biochemical markers used to assess function, only alkaline phosphatase, a marker of cholestasis, showed a modest improvement in the absence of p53, while total bilirubin levels remained elevated and ALT and AST levels increased further indicating that loss of p53 was exacerbating hepatocyte dysfunction, rather than improving it (S18 Fig).